Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Other specified types of non-Hodgkin's lymphoma, lymph nodes of inguinal region and lower limb
- C85.75
Summary
Other specified types of non-Hodgkin's lymphoma, lymph nodes of inguinal region and lower limb, is a subtype of non-Hodgkin lymphoma (NHL) involving the lymph nodes in the inguinal region (groin) and lower limb. This code applies when the lymphoma type is known but not classified into a more specific subcategory, and the site of involvement is limited to these areas. NHL arises from abnormal lymphocyte growth in the lymphatic system, which is part of the immune system.
Causes
The exact cause of this condition is often unknown but involves genetic mutations in lymphocytes. Factors such as viral infections (e.g., Epstein-Barr virus), immune system disorders, or exposure to certain chemicals may contribute to its development. These mutations disrupt normal cell regulation, leading to uncontrolled growth.
Risk Factors
- Advanced age (more common in older adults)
- Weakened immune system (e.g., HIV/AIDS, immunosuppressive therapy)
- Certain infections (e.g., hepatitis C, H. pylori)
- Exposure to chemicals (e.g., pesticides, herbicides)
- Family history of lymphoma
- Autoimmune conditions (e.g., rheumatoid arthritis)
Symptoms
- Swollen lymph nodes in the groin or lower limb
- Fever, night sweats, or unexplained weight loss
- Fatigue or weakness
- Persistent itching (pruritus)
- Abdominal pain or discomfort (if lymph nodes are enlarged)
Diagnosis
Diagnosis typically involves a physical examination to check for swollen lymph nodes, followed by imaging tests (e.g., CT scan, MRI) to assess the extent of lymph node involvement. A biopsy of the affected lymph node is usually performed to confirm the diagnosis and determine the lymphoma subtype. Additional tests, such as blood work or bone marrow biopsy, may be done to evaluate overall health and disease spread.
Treatment Options
Treatment depends on the lymphoma subtype, stage, and patient health. Common approaches include chemotherapy, immunotherapy, radiation therapy, or a combination of these. Targeted therapies or stem cell transplantation may be considered for certain cases. Treatment plans are tailored to the individual and may involve a multidisciplinary team of specialists.
Prognosis and Follow-Up
Prognosis varies based on the lymphoma subtype, stage at diagnosis, and patient response to treatment. Regular follow-up appointments are essential to monitor for recurrence or complications. Follow-up may include physical exams, imaging, or blood tests. Long-term surveillance is often recommended, even after successful treatment.
Complications
Potential complications include infection due to weakened immunity, organ damage from enlarged lymph nodes, or side effects from treatment (e.g., fatigue, nausea). In advanced cases, lymphoma may spread to other organs, leading to more severe symptoms or functional impairment.
Lifestyle & Prevention
While prevention is not always possible, maintaining a healthy immune system through balanced nutrition, regular exercise, and avoiding known risk factors (e.g., excessive chemical exposure) may help reduce risk. Staying up-to-date with vaccinations and managing underlying conditions (e.g., HIV) can also support immune health.
When to Seek Professional Help
Seek medical attention if you experience persistent swollen lymph nodes, unexplained weight loss, fever, or other concerning symptoms. Early evaluation is important for timely diagnosis and treatment. Contact a healthcare provider if symptoms worsen or do not improve with initial care.
Tips for Medical Coders
Use C85.75 when documenting other specified types of non-Hodgkin's lymphoma with involvement of the inguinal region and lower limb lymph nodes. Ensure the lymphoma type is not classified under a more specific code and that the site is clearly documented. Verify that the code aligns with clinical documentation to avoid miscoding.
C85.75 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.